TMDX

NASDAQ 已收盘

TransMedics Group

94.02 USD
▼-2.41-2.50%
盘后 93.69 -0.35%
2026-11-19
市值
$2.96B
市盈率
22.00
EPS
3.88
股息率
—
52 周区间
60.11 – 156.00
成交量
1.01M
Beta
2.10
目标价
105.45
52W 低 60.1152W 高 156.00
价格走势

公司简介

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung tra...